Natural Product: NPC596167

Natural Product IDNPC596167
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
[(1~{R},3~{a}~{R},5~{a}~{R},5~{b}~{R},7~{a}~{R},9~{R},11~{a}~{R},13~{a}~{R})-1-isopropenyl-3~{a},5~{a},5~{b},8,8,11~{a}-hexamethyl-1,2,3,4,5,6,7,7~{a},9,10,11,11~{b},12,13,13~{a},13~{b}-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate
IUPAC Name [(1~{R},3~{a}~{R},5~{a}~{R},5~{b}~{R},7~{a}~{R},9~{R},11~{a}~{R},13~{a}~{R})-1-isopropenyl-3~{a},5~{a},5~{b},8,8,11~{a}-hexamethyl-1,2,3,4,5,6,7,7~{a},9,10,11,11~{b},12,13,13~{a},13~{b}-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey ODSSDTBFHAYYMD-HTQIIGDOSA-N
Standard InCHI InChI=1S/C32H52O2/c1-20(2)22-12-15-29(6)18-19-31(8)23(27(22)29)10-11-25-30(7)16-14-26(34-21(3)33)28(4,5)24(30)13-17-32(25,31)9/h22-27H,1,10-19H2,2-9H3/t22-,23+,24-,25?,26+,27?,29+,30-,31+,32+/m0/s1
SMILES C=C(C)[C@@H]1CC[C@]2(C)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC[C@@H](OC(C)=O)C(C)(C)[C@@H]5CC[C@]43C)C12

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   468.4 Volume:   531.553
?
Van der Waals volume.
Dense:   0.881 LogP:   6.154
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   4.686
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -7.147
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   3.0 Rigid Bonds:   27.0
TPSA:   26.3
?
Topological Polar Surface Area.
H-Bond Acceptor:   2.0
H-Bond Donor:   0.0 Rings:   5.0
Heavy Atoms:   2.0

MedChem Properties

QED Drug-Likeness Score:   0.299 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.692 Fsp3:   0.906
MCE-18:   102.164
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.976 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.001
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.0
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.613 Promiscuous compounds:   0.157

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.067 MDCK Permeability:   -4.871
Pgp-inhibitor:   0.998 Pgp-substrate:   0.0
PAMPA:   0.005
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.075 30% Bioavailability (F30%):   0.078
50% Bioavailability (F50%):   0.955

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.092 MRP1:   0.857
Plasma Protein Binding (PPB):   97.438% Volume Distribution (VD):   0.258
Fu: 2.855%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   0.971 BCRP inhibitor:   0.102
BSEP inhibitor:   1.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.454 CYP1A2-substrate:   0.093
CYP2C19-inhibitor:   1.0 CYP2C19-substrate:   0.129
CYP2C9-inhibitor:   0.066 CYP2C9-substrate:   0.132
CYP2D6-inhibitor:   0.035 CYP2D6-substrate:   0.005
CYP3A4-inhibitor:   0.179 CYP3A4-substrate:   0.998
CYP2B6-substrate:   0.344 CYP2C8-inhibitor:   0.996
HLM stability:   0.931
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  8.885 Half-life (T1/2):  0.208

ADMET: Toxicity

hERG Blockers:  0.074 hERG Blockers (10um):  0.363
Human Hepatotoxicity (H-HT):  0.635 Drug-induced Liver Injury (DILI):  0.3
AMES Toxicity:  0.207 Rat Oral Acute Toxicity:  0.359
Maximum Recommended Daily Dose:  0.501 Skin Sensitization:  0.901
Carcinogencity:  0.904 Eye Corrosion:  0.259
Eye Irritation:  0.722 Respiratory Toxicity:  0.768
Drug-induced Neurotoxicity:  0.054 Ototoxicity:  0.37
Hematotoxicity:  0.331 Drug-induced Nephrotoxicity:  0.464
Genotoxicity:  0.121 RPMI-8226 Immunitoxicity:  0.025
A549 Cytotoxicity:  0.278 Hek293 Cytotoxicity:  0.466
BCF:   2.677
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   5.287
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.026
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   6.263
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO15315 Boswellia carterii Species Burseraceae Eukaryota n.a. n.a. n.a. PMID[24195447]
NPO15315 Boswellia carterii Species Burseraceae Eukaryota Gum resin n.a. n.a. PMID[26457560]
NPO8402 Thevetia peruviana Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[26714048]
NPO8402 Thevetia peruviana Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[39027575]
NPO15315 Boswellia carterii Species Burseraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO8402 Thevetia peruviana Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO15315 Boswellia carterii Species Burseraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO15315 Boswellia carterii Species Burseraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO15315 Boswellia carterii Species Burseraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO15315 Boswellia carterii Species Burseraceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO15315 Boswellia carterii Species Burseraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO8402 Thevetia peruviana Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC596167 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC305835
0.8519 High Similarity NPC611062
0.7679 Intermediate Similarity NPC98270
0.7636 Intermediate Similarity NPC84868
0.7544 Intermediate Similarity NPC5280
0.7541 Intermediate Similarity NPC475416
0.7414 Intermediate Similarity NPC304194
0.7414 Intermediate Similarity NPC473742
0.7188 Intermediate Similarity NPC239362
0.6949 Remote Similarity NPC481227
0.6833 Remote Similarity NPC261616
0.6721 Remote Similarity NPC168231
0.6667 Remote Similarity NPC474092
0.6452 Remote Similarity NPC471901
0.625 Remote Similarity NPC473690
0.614 Remote Similarity NPC43300
0.6094 Remote Similarity NPC4309
0.5968 Remote Similarity NPC61107
0.5965 Remote Similarity NPC192638
0.5965 Remote Similarity NPC25511
0.5965 Remote Similarity NPC600137
0.5833 Remote Similarity NPC475509
0.5833 Remote Similarity NPC488509
0.5781 Remote Similarity NPC303863
0.5738 Remote Similarity NPC302280
0.5606 Remote Similarity NPC180204
0.5484 Remote Similarity NPC269396
0.5441 Remote Similarity NPC160506
0.541 Remote Similarity NPC293803
0.5385 Remote Similarity NPC488508
0.5333 Remote Similarity NPC102708
0.5323 Remote Similarity NPC159497
0.5303 Remote Similarity NPC31031
0.5263 Remote Similarity NPC473612
0.5254 Remote Similarity NPC35652
0.5231 Remote Similarity NPC190940
0.5231 Remote Similarity NPC488510
0.5211 Remote Similarity NPC471902
0.519 Remote Similarity NPC148404
0.519 Remote Similarity NPC35212
0.5167 Remote Similarity NPC80297
0.5167 Remote Similarity NPC475727
0.5167 Remote Similarity NPC116119
0.5161 Remote Similarity NPC248830
0.5161 Remote Similarity NPC212241
0.5156 Remote Similarity NPC132386
0.5156 Remote Similarity NPC103754
0.5132 Remote Similarity NPC473844
0.5077 Remote Similarity NPC12774
0.5075 Remote Similarity NPC607755
0.507 Remote Similarity NPC287118

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC596167 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5441 Remote Similarity NPD8035 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data